Clinical Connection

A phase 2 open-label study of brentuximab vedotin in front-line therapy of Hodgkin Lymphoma (HL) in patients with significant comorbidities who are ineligible to be treated with standard chemotherapy

Question 1 of 7

Have you been diagnosed with Hodgkin Lymphoma?